Ribonucleotide Reductase: A Mechanistic Portrait of Substrate Analogues Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2854-2872
Author(s):
M.A.S. Perez, N.M.F.S.A. Cerqueira, P.A. Fernandes and M.J. Ramos
Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2873-2881
Author(s):
G. Klamer, E. Song, K-H. Ko, T.A. O'Brien and A. Dolnikov
Infrared-Spectroscopy: A Non-Invasive Tool for Medical Diagnostics and Drug Analysis
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
2956-2966
Author(s):
H. Hahn, J.D. Pallua, C. Pezzei, V. Huck-Pezzei, G.K. Bonn and C.W. Huck
Inhibiting Breast Cancer Progression by Exploiting TGFβ Signaling
Journal:
Current Drug Targets
Volume:
11
Page:
1089-1102
Author(s):
Sarah E. Baxley and Rosa Serra
Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Journal:
Current Drug Targets
Volume:
11
Page:
1147-1156
Author(s):
Arindam Pal, Kelli E. Valdez, Martha Z. Carletti and Fariba Behbod
Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO
Journal:
Current Drug Targets
Volume:
11
Page:
1181-1191
Author(s):
Christian Wichmann, Manuel Grez and Jorn Lausen
Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Journal:
Current Genomics
Volume:
11
Page:
409-419
Author(s):
Maj A. Hulten, Jon Jonasson, Ann Nordgren and Erik Iwarsson
A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
3262-3288
Author(s):
M. Wojcik, I. Burzynska-Pedziwiatr and L. A. Wozniak
Bisphosphonate Therapy in the Treatment of Multiple Myeloma
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3028-3036
Author(s):
M. A. Lawson, J. Ashcroft and P. I. Croucher
Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Journal:
Current Drug Metabolism
Volume:
11
Page:
603-617
Author(s):
Zhanglin Ni, Zsolt Bikadi, Mark F. Rosenberg and Qingcheng Mao